Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes
- Conditions
- Periorbital Wrinkles
- Interventions
- Device: Ulthera™ System
- Registration Number
- NCT00747422
- Lead Sponsor
- Ulthera, Inc
- Brief Summary
The purpose of this study is to look at how safe and effective the Ulthera ultrasound system is at reducing the appearance of wrinkles when used with subjects who have wrinkles around the eyes.
- Detailed Description
The purpose of this prospective, multi-center, single treatment, clinical trial is to evaluate the effectiveness and safety of the Ulthera™ System for the non-invasive treatment of periorbital wrinkles and rhytids.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Male or female, aged 40 to 70 years
- Subject in good health
- Desire improvement in periorbital wrinkles
- Subject provides informed consent and agrees to attend follow-up visits
- Subject signs a HIPPA authorization
- Pregnant or lactating
- Has an active systemic or local skin disease that may alter wound healing
- Has significant scarring in test areas
- Has significant open facial wounds or lesions
- Has severe or cystic acne on the face
- Has a metal stent or implant in the face area
- Is a current smoker or has a history of smoking in last 10 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description I Ulthera™ System -
- Primary Outcome Measures
Name Time Method reduction of periorbital wrinkles 3 and 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Scripps Clinic Carmel Valley, Division of Laser and Cosmetic Dermatology
🇺🇸San Diego, California, United States
Northwestern University Department of Dermatology
🇺🇸Chicago, Illinois, United States
SkinCare Physicians
🇺🇸Chestnut Hill, Massachusetts, United States
Zel Skin and Laser Specialists
🇺🇸Edina, Minnesota, United States